PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. Show more
150 Baytech Drive, San Jose, CA, 95134, United States
Start AI Chat
Market Cap
1.529B
52 Wk Range
$26.23 - $70.80
Previous Close
$27.36
Open
$27.29
Volume
1,329,263
Day Range
$26.80 - $28.32
Enterprise Value
1.713B
Cash
294.3M
Avg Qtr Burn
-6.635M
Insider Ownership
4.44%
Institutional Own.
-
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
